Overview

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients

Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
To investigate the influence of hepatic steatosis on the anti-viral effect of entecavir in chronic hepatitis B patients.
Phase:
Phase 4
Details
Lead Sponsor:
Zhejiang University
Treatments:
alpha-Tocopherol
Entecavir
Essential 303 forte
Tocopherols
Tocotrienols
Vitamin E
Vitamins